Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Caris Life Sciences revenue
Caris Life Sciences's revenue is $13.0 million.
What is Caris Life Sciences's revenue?
- Caris Life Sciences has 843 employees, and the revenue per employee ratio is $15,421.
- Caris Life Sciences peak revenue was $13.0M in 2024.
On this page
Zippi applies for you, and finds you a job.
Caris Life Sciences financing
Caris Life Sciences received early financing of $150.0M on 2018-10-01.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $150M | 10/2018 |
| Debt Financing | $75M | 10/2020 |
| Private Equity | $235M | 10/2020 |
| Private Equity | $830M | 05/2021 |
Caris Life Sciences investors
| Investors | Security type |
|---|---|
| Armentum Partners | Debt Financing |
| Sixth Street | Debt Financing |
| Sixth Street | Debt Financing |
| Coatue | Private Equity |
| Clearbridge Investments LLC | Private Equity |
| Neuberger Berman | Private Equity |
| First Light | Private Equity |
| Sixth Street | Private Equity |
| Millennium Management | Private Equity |
| OrbiMed Advisors | Private Equity |
| T. Rowe Price | Private Equity |
| HIGHLAND CAPITAL MANAGEMENT | Private Equity |
| Neuberger Berman | Private Equity |
| SILVER LAKE | Private Equity |
| First Light | Private Equity |
| Millennium Management | Private Equity |
| Fidelity Management & Research Co LLC | Private Equity |
| HIGHLAND CAPITAL MANAGEMENT | Private Equity |
| Coatue | Private Equity |
| Clearbridge Investments LLC | Private Equity |
| Columbia Threadneedle Investments | Private Equity |
| Sixth Street | Private Equity |
| Tudor Investments | Private Equity |
| EATON VANCE CORP | Private Equity |
| OrbiMed Advisors | Private Equity |
| CPP Investment Board | Private Equity |
| T. Rowe Price | Private Equity |
| Rock Springs Capital | Private Equity |
| Pura Vida Investments LLC | Private Equity |
Caris Life Sciences competitors
Caris Life Sciences's top competitor, Miraca Life Sciences, earned an annual revenue of $390.0M.
Caris Life Sciences's smallest competitor is NanoCellect Biomedical with revenue of $3.1M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| PathGroup | $33,174 | $97.0M | 800 | 130 |
| Incyte Diagnostics | $45,031 | $13.9M | 200 | 14 |
| Inform Diagnostics | $82,696 | $31.5M | 750 | - |
| CBLPath | $49,052 | $11.8M | 200 | 11 |
| Avero Diagnostics | $46,779 | $7.2M | 114 | - |
| NanoCellect Biomedical | $44,823 | $3.1M | 66 | - |
| Miraca Life Sciences | $47,886 | $390.0M | 3,000 | - |
| Foundation Medicine | $94,749 | $152.9M | 1,300 | 26 |
| Diatherix | $50,083 | $10.0M | 163 | - |
| Tempus | $74,973 | - | 751 | 147 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Caris Life Sciences highest paying jobs
Zippia gives an in-depth look into the details of Caris Life Sciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Caris Life Sciences. The employee data is based on information from people who have self-reported their past or current employments at Caris Life Sciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Caris Life Sciences. The data presented on this page does not represent the view of Caris Life Sciences and its employees or that of Zippia.
Caris Life Sciences may also be known as or be related to Caris Life Sciences, Caris Life Sciences, Inc. and Caris Ltd. II, L.P.